Randomised, double-blind, phase III study comparing the infliximab biosimilar, PF-06438179/GP1111, with reference infliximab: efficacy, safety and immunogenicity from week 30 to week 54 - Concepedia

Concepedia

Publication | Open Access

Randomised, double-blind, phase III study comparing the infliximab biosimilar, PF-06438179/GP1111, with reference infliximab: efficacy, safety and immunogenicity from week 30 to week 54

DOI Full Paper Access

25

Citations

21

References

2019

Year

Rieke Alten, Bogdan Batko, Tomas Hala, Hideto Kameda, S. Radominski, Vira Tseluyko, Goran Babić, Carol Cronenberger, Sarah Hackley, Muhammad Rehman,

Abstract

NCT02222493.

References

	Year	Citations

Page 1